Prothena Co. plc (NASDAQ:PRTA – Get Free Report) COO Brandon S. Smith sold 4,000 shares of the firm’s stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $55.49, for a total transaction of $221,960.00. The sale was disclosed in a filing with the Securities & Exchange Commission, […]
Prothena (NASDAQ:PRTA – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a report released on Monday. A number of other analysts have also commented on PRTA. Cantor Fitzgerald reiterated an “overweight” rating and issued a $129.00 price target on shares of Prothena in a […]
Oppenheimer & Co. Inc. purchased a new position in shares of Prothena Co. plc (NASDAQ:PRTA – Free Report) during the 1st quarter, Holdings Channel.com reports. The firm purchased 7,270 shares of the biotechnology company’s stock, valued at approximately $352,000. Other hedge funds and other institutional investors have also recently bought and sold shares of the […]
Analysts Set Prothena Co plc (NASDAQ:PRTA) Target Price at $87 56 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Cantor Fitzgerald reiterated their overweight rating on shares of Prothena (NASDAQ:PRTA – Free Report) in a report published on Tuesday, Benzinga reports. Cantor Fitzgerald currently has a $129.00 price target on the biotechnology company’s stock. Several other equities analysts have also weighed in on PRTA. JMP Securities lifted their target price on shares of Prothena […]